Additive Orthopaedics Announces the 510(k) Clearance of Their 3D Printed Osteotomy Wedge System for the Global Extremities Market

LITTLE SILVER, N.J., Sept. 8, 2016 /PRNewswire/ — Additive Orthopaedics, LLC., an early stage orthopaedic device company, today announced that is has received FDA 510(k) clearance for its 3D printed osteotomy wedge system, to address bone fractures or osteotomies in the foot and ankle. This is the Company’s second innovative device leveraging additive manufacturing that has been cleared through the FDA.

According to Dr. Selene Parekh, Professor of Surgery in the Department of Orthopaedic Surgery at Duke Orthopaedics and North Carolina Orthopaedic Clinic, “The complex geometry and unique lattice structure, which is only possible through the use of 3D printing technology, should have tremendous patient benefits.  Solutions like these, as well as custom and patient specific applications of this technology, will continue to have a major impact on how we treat our patients.”

About Additive Orthopaedics, LLC.
Additive Orthopaedics is an early stage orthopaedic company focused on leveraging the patient, technological and cost benefits of additive manufacturing into the global extremities market.

Greg Kowalczyk

Logo –

SOURCE Additive Orthopaedics, LLC.


Drue is Managing Partner for The De Angelis Group.

Related Articles

Back to top button